How do clinicians practicing in the U.S. Manage Helicobacter pylori- related gastrointestinal diseases? A comparison of primary care and specialist physicians

American Journal of Gastroenterology

Volumn 93, Issue 4, 1998, Pages 553-561

  Breuer, Thomas ^b   Goodman, Karen J ^b   Malaty, Hoda M ^b   Sudhop, Thomas ^b   Graham, David Y ^a  

^a Medical Center (111 D)   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTACID AGENT; ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; PROTON PUMP INHIBITOR;

ANTIMICROBIAL THERAPY; ARTICLE; EVIDENCE BASED MEDICINE; GASTROINTESTINAL INFECTION; GENERAL PRACTITIONER; HELICOBACTER PYLORI; HUMAN; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL SPECIALIST; NORMAL HUMAN; PEPTIC ULCER; PRIORITY JOURNAL; SCREENING TEST;

GASTROENTEROLOGY; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INFORMATION SERVICES; PEPTIC ULCER; PHYSICIANS, FAMILY; QUESTIONNAIRES; UNITED STATES;

EID: 0001043167     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.164_b.x     Document Type: Article

References (45)

1. 1. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437-42.
2. 2. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705-8.
3. 3. Correa P, Ruiz B, Hunter F. Clinical trials as etiologic research tools in Helicobacter-associated gastritis. Scand J Gastroenterol 1991; 181(suppl):15-9.
4. 4. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
5. 5. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
6. 6. Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
7. 7. Fukao A, Komatsu S, Tsubono Y, et al. Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: A cross-sectional study. Cancer Causes Control 1993;4:307-12.
8. 8. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 1991;302:1302-5.
9. 9. Craanen ME, Dekker W, Blok P, et al. Intestinal metaplasia and Helicobacter pylori: An endoscopic bioptic study of the gastric antrum. Gut 1992;33:16-20.
10. 10. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705-8.
11. 11. Graham DY, Hepps KS, Ramirez FC, et al. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993;28:939-42.
12. 12. Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995;345:1591-4.
13. 13. Stolte M. Helicobacter pylori gastritis and gastric MALT-lymphoma. Lancet 1992;339:745-6.
14. 14. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Working Group: Schistosomes, liver flukes and Helicobacter pylori. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
15. 15. Greenberg RE, Bank S. The prevalence of Helicobacter pylori in nonulcer dyspepsia. Importance of stratification according to age. Arch Intern Med 1990;150:2053-5.
16. 16. Talley NJ. The role of Helicobacter pylori in nonulcer dyspepsia. A debate against. Gastroenterol Clin North Am 1993;22:153-67.
17. 17. Holtmann G, Goebell H, Holtmann M, et al. Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci 1994;39:1090-8.
18. 18. Colin-Jones DG. Dyspepsia update. Scand J Gastroenterol 1995; 210(suppl):32-5.
19. 19. Siebert C, Lipsett LF, Greenblatt J, et al. Survey of physician practice behaviors related to diabetes mellitus in the U.S. I. Design and methods. Diabetes Care 1993;42:759-64.
20. 20. Helicobacter pylori in peptic ulcer disease. NIH Consensus Statement 1994;12:1-23.
21. 21. van der Hulst RWM, Keller JJ, Rauws EA, et al. Treatment of Helicobacter pylori infection in humans: A review of the world literature. Helicobacter 1996;1:6-19.
22. 22. Bazzoli F, Zagari RM, Fossi S, et al. Short term, low dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-7.
23. 23. Labenz J, Rühl GH, Stolte M, et al. Efficacy of low-dose one-week triple therapy to cure H. pylori infection. Am J Gastroenterol 1994; 89:A364.
24. 24. Labenz J, Stolte M, Rühl G, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995;7:9-11.
25. 25. Chiba N, Rao BV, Rademaker JW, et al. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716-27.
26. 26. de Boer W, Driessen W, Jansz A, et al. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345:817-20.
27. 27. de Boer WA, Driessen WM, Potters VP, et al. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994;89:1993-7.
28. 28. Heatley RV. Review article. The treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1992;6:291-303.
29. 29. Bayerdörffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995;345:1591-4.
30. 30. Cammarota G, Tursi A, Montalto M, et al. Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H. pylori therapy. J Clin Gastroenterol 1995;21:118-22.
31. 31. Binek J, Morant R, Weber A, et al. MALT-type low-grade B-cell lymphomas of the stomach and Helicobacter pylori. Schweizerische Medizinische Wochenschrift 1996;841-4.
32. 32. Alkan S, Karcher DS, Newman MA, et al. Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori. Lancet 1996;348:268-9.
33. 33. Shahar E, Bisgard KM, Folsum AR. Response to mail surveys: Effect of a request to explain refusal to participate. Epidemiology 1993;4:480-2.
34. 34. Asch AA, Christakis NA. Different response rates in a trial of two envelope styles in mail survey research. Epidemiology 1994;5:364-5.
35. 35. Dillman D. Mail and Telephone Surveys: The Total Design Method. John Wiley & Sons, New York, 1978.
36. 36. Christensen AH, Logan RP, Noach LA, et al. Do clinicians accept the role of Helicobacter pylori in duodenal ulcer disease: A survey of European gastroenterologists and general practitioners. J Intern Med 1994;236:501-5.
37. 37. Babbs C. H. pylori-associated gastroduodenal disease: Survey of British physicians' views. Gut 1995;37(suppl 1):347.
38. 38. Breuer T, Sudhop T, Goodman KJ, et al. How do practicing clinicians manage Helicobacter pylori-related gastrointestinal diseases in Germany? A survey of gastroenterologists and family practitioners. Helicobacter 1998;1:1-8.
39. 39. Fendrick AM, Hirth RA, Chernew ME. Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease. Am J Gastroenterol 1996;91:1544-8.
40. 40. Labenz J, Gyenes E, Ruhl GH, et al. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: A prospective, randomized, and controlled study. Gut 1993;34:1167-70.
41. 41. Labenz J, Gyenes E, Rühl GH, et al. Omeprazole plus amoxicillin: Efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993;88:491-5.
42. 42. Bayerdörffer E, Mannes GA, Sommer A, et al. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992;4:697-702.
43. 43. Graham KS, Malaty H, el-Zimaity HM, et al. Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Am J Gastroenterol 1995;90:1415-8.
44. 44. van der Hulst RW, Weel JF, Verheul SB, et al. Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxycillin and the effect of early retreatment. Aliment Pharmacol Ther 1996;10:165-71.
45. 45. Gisbert JP, Mur M, Sainz S, et al. Is the omeprazole and amoxicillin combination useful in the treatment eradicating Helicobacter pylori in Spain? Rev Esp Enferm Dig 1996;88:99-106.